ISOPP CAPhO Symposium 2025

Melanie Dorey is a registered pharmacy technician and has worked in the compounding industry since 2006. She graduated from a 2-year Pharmacy Technician program in 2006 and at the Children’s Hospital of Eastern Ontario (CHEO) where she acquired a passion for sterile and nonsterile compounding. While attending the Sterile Compounding Boot Camp in Denver, Colorado in 2007, Melanie met several key industry experts who ignited her passion for sterile and nonsterile compounding. In 2014, she joined the team at CriticalPoint and Kastango Consulting Group where she continued to hone her skills while developing eLearning, standard operating procedures, as well as in person and virtual lectures. She also traveled to client locations to perform competency assessment and customized training. Melanie has served on a variety of committees with NAPRA and the Ontario College of Pharmacy. Melanie is the owner of Critical Compounding Resources which offers services to compounding operations across North America. 

Mary Nazzal, a PharmD, Registered Pharmacist, is the Co-owner and Director of Field Operations for Critical Compounding Resources LLC (CCR). She received her PharmD degree from Butler University of Indianapolis and has completed the Nuclear Pharmacy Certificate Program at Purdue University. Mary received her Compounded Sterile Preparations Certification from the Board of Pharmacy Specialties in the fall of 2019 as a member of its inaugural class.

She has over 18 years of progressive and diverse hospital pharmacist experience, including administrative, inpatient pharmacy, de-centralized pharmacy, and operating room, focusing on sterile compounding. Before co-owning CCR LLC, Mary was the Director of Field Operations for Kastango Consulting Group, a TRC Healthcare Company, where she directed the day-to-day consulting operations. Before that, Mary established and led sterile compounding services, including pharmacy-related policy/procedure/SOP development, technology setup and implementation, training development, and execution for Cleveland Clinic, Abu Dhabi, in the United Arab Emirates. She currently performs gap analysis, facility design development, and review of construction documents for clients to ensure regulatory compliance and provide best practice recommendations regarding compounding. In addition, she is involved in product development for CCR. She is also a member of the American Society of Health-System Pharmacists (ASHP), Indiana Pharmacists Association, Controlled Environment Testing Association (CETA) and the Parenteral Drug Association (PDA). She recently became a member of the ASHP Section of Inpatient Care Practitioners Section Advisory Groups: Compounding Practice.

Mark, a seasoned professional with over 30 years of diverse experience.

With a background encompassing Department of Defense, Federal Government, and private sector Industrial Hygiene roles, Mark brings expertise in healthcare, Biosafety laboratory/research, and specialty evaluation and certification of controlled environments.

Previously, he served as the National Industrial Hygiene Program Manager for the Department of Veterans Affairs, overseeing Occupational Safety and Health and USP 797/800 policy development, implementation, and compliance across 175+ Medical Centers.

A retired U.S. Air Force Industrial Hygiene Bioenvironmental Engineering Professional, he holds certifications as a Certified Industrial Hygienist (CIH), and Controlled Environment Testing Association CNBT Registered Certification Professional for Sterile Compounding Facilities (RCCP-SCF).

Mark is dedicated to STEM education and training. During his tenure at the USAF School of Aerospace Medicine, he instructed new Air Force enlisted and officer Industrial Hygiene Bioenvironmental Engineering Airmen, teaching a comprehensive curriculum covering industrial hygiene principles, analytical chemistry, air monitoring techniques, and more. Mark is currently an Adjunct Instructor in the Certification of Sterile Compounding Facilities Course at the Eagleson Institute, Sanford, ME.

Scott Edwards is currently the Clinical Oncology Pharmacy Specialist at the Dr. H. Bliss Murphy Cancer Center in St. John’s, Newfoundland. He is also an assistant professor at the School of Pharmacy and the Discipline of Oncology, Faculty of Medicine, Memorial University of Newfoundland. He is active in clinical cancer research in the area of chemotherapy toxicities, supportive care and oral chemotherapy adherence. He graduated from Memorial University of Newfoundland with a B.Sc. (Neuroscience) in 1994 and a B.Sc (Pharmacy) in 1997. In 2005, he graduated with a Doctor of Pharmacy degree from the University of Washington. He completed a Master’s degree in Oncology from Newcastle University in 2015.

Clinical Resource Pharmacist (Oncology) providing care for patients receiving oral anti-cancer therapies.

Dr. Christine Peragine is the Lead Pharmacist for Sunnybrook’s Oral Anticancer Medication (OAM) Program at the Odette Cancer Centre, Toronto, Ontario, Canada. Christine graduated from the University of Toronto combined BScPhm-PharmD program in 2015 and started her PhD training and Antimicrobial Stewardship-Infectious Disease Pharmacy Fellowship in the same year. She has worked in Ambulatory Oncology since 2018 and is passionate about advancing pharmacy practice, research, and education. Over the course of her career, Dr. Peragine has spearheaded over 25 practice-based research initiatives, published over 30 unique abstracts, and presented at over 15 academic conferences. She has received over $110,000 CAD in grant funding and was the recipient of the 2022 Sunnybrook Practice-Based Research and Innovation Award of Inquiry. Her commitment to teaching is demonstrated by the number of students and trainees she has precepted (>30), and the creation and launch of clinical and research co-op opportunities with the OAM Team in Fall 2022.

Dr. Kaitlyn Watson, an Australian registered pharmacist began her pharmacy career working in an Oncology Day Unit at Greenslopes Private Hospital, Australia. Dr Watson went on to become a globally recognized disaster pharmacy researcher, serving as the Founder & CEO of Disaster Pharmacy Solutions. She specializes in delivering disaster management and emergency preparedness training to the pharmacy workforce through interactive Table-Top Exercises. In 2022, Kaitlyn authored the foundational book 'Disaster and Emergency Pharmacy: A Guide to Preparation and Management' published by Routledge. 

Dr. Watson is an Assistant Professor at the University of Alberta's Faculty of Pharmacy and Pharmaceutical Sciences, focusing on social and public health pharmacy. Dr. Watson earned her PhD in Pharmacy Practice and Disaster Management from Queensland University of Technology, Australia. Her doctoral research focused on a comprehensive exploration of pharmacists' roles and responsibilities in both natural and anthropogenic disasters and emergencies. Additionally, with expertise gained through two postdoctoral fellowships in clinical trial management and implementation science, Dr. Watson is dedicated to sustainable evidence-based change in the public health and primary care sectors. 

PhD in Public Health, Specialist in Hospital Pharmacy in Logistics Operations Management. Works as a pharmacist in the Supply Division of the Brazilian National Cancer Institute (INCA), teaching postgraduate courses in Hospital Pharmacy, in INCA's Multiprofessional Residency Program in Oncology and in the Research Program in Collective Health and Cancer Control/INCA. President of the Brazilian Society of Oncology Pharmacists (SOBRAFO) for the 2025-2026 term. She has experience in Service Management, Supply Logistics and teaching in areas of Pharmaceutical Services and Public Procurement.

• Top40 Under40, Kenya 2021
• University of Nairobi, Kenya, Bachelor of Pharmacy
• Strathmore University, Kenya, Health leadership and Management
• Liverpool John Moore University, UK, Msc International Public Health
• Vienna School of Clinical Research Public Health And Medical Education, VSCR,  Diploma Health Economics and Outcomes Research 
• Chairperson Pharmaceutical society of Kenya, PSK, Tana Athi Branch, 
• Member, National Governing Council, Pharmaceutical Society of Kenya PSK

Lynne Nakashima received her BSc(Pharm) from the University of British Columbia, Canada and her PharmD from the University of North Carolina at Chapel Hill, USA. Lynne is a Fellow of both CAPhO and ISOPP and is currently the Chair of the ISOPP Grants and Awards Task Force as well as the CAPhO Fellow Task Force. She is currently the Senior Director, Provincial Pharmacy at BC Cancer in Canada where she is responsible for pharmacy professional practice leadership, provincial oncology medication management, support for the systemic therapy program and leadership for the Pharmacy Residency Program.

Shellyza Sajwani is a pharmacist who works within areas of oncology, climate change and global health as they relate to the pharmacy profession. Shellyza received her MPharm from Aston University in the UK, her PharmD from the University of Toronto, her Climate Change and Health certification from Yale University and her Global Health Intensive Delivery Certification from Harvard University . She is currently an adjunct professor at the University of Ottawa, and the national co-chair of the Canadian Association of Pharmacy for the Environment (CAPhE - pronounced Caa-fee ). She has also worked for many years as an oncology pharmacist at the Ottawa Hospital, with ten years of experience in a combination of outpatient and inpatient oncology, and also co-chairs the Ottawa Hospital Pharmacy Environmental Committee. 

Shellyza co-chaired the International Pharmaceutical Federation (FIP) policy committee, which created and passed the first ever international pharmacy climate change policy in 2023 which went to the over 100 country membership representing four million pharmacy professionals. She also represented the University of Ottawa and the CAPhE at the United Nations COP29 conference in 2024 . Shellyza is currently the co-founder of Climaceutics Health Solutions which focuses on building on tools and certifications  for pharmacies to reduce their emissions and improve their climate resilience. 

Shellyza also has experience working as a previous co-president of Pharmacists Without Borders Canada ; and has received CAPhO Merit awards for her work as an oncology pharmacy consultant in Gulu, Uganda in 2017 and 2018, as well as her later work advocating for cancer patients with various patient advocacy organizations during her own chemotherapy treatment and during her remission. 

Data-driven healthcare improvement is at the heart of Shirley Yeung's work as Provincial Pharmacy Information Systems Coordinator at BC Cancer. She ensures safe and effective pharmacy services by overseeing the selection, implementation, and maintenance of pharmacy computer systems and managing drug inventory and contracting. With a background in pharmaceutical sciences (UBC, 2009), a hospital pharmacy residency, and a Master's in Public Health (Health Economics) from the London School of Hygiene and Tropical Medicine (2014), Shirley brings a strong analytical lens to her role. In her free time, she enjoys swimming.

Katie Lacaria is a clinical pharmacy educator in leukemia and bone marrow transplantation at Vancouver General Hospital. She completed a Hospital Pharmacy Residency Program from the University of British Columbia (UBC). She is a Clinical Instructor at UBC and a Clinical Consultant for Pharmacist’s Letter Canada. Her areas of expertise and research interests include immunosuppressive pharmacotherapy, transplant-related infections, and drug allergies.

Anita Mucua is an Oncology Pharmacist at the Kenyatta University Teaching, Research, and Referral Hospital (KUTRRH), a national hospital in Kenya. She spearheaded the establishment and operationalization of the oncology pharmacy and oncology pharmacy practice in the hospital. She also led the implementation of bedside Medication Therapy management (MTM) for oncology patients undergoing chemotherapy. 

She is a member of ISOPP, Hospital Pharmacists Association of Kenya (HOPAK), Kenya Society of Haematology and Oncology (KESHO) and British Oncology Pharmacy Association (BOPA). She was a member of the organizing task force for the first African Regional Oncology Pharmacy Symposium (AROPS) 2019 where ISOPP collaborated with HOPAK, in addition to being in the organizing committee for HOPAK annual symposiums. She is member of the symposium scientific program task force for ISOPP CAPHO 2025. 

She attained MSc Clinical Oncology at the University of Birmingham in the United Kingdom, including a 6-month NHS observer ship at Queen Elizabeth Hospital. She worked closely with specialist pharmacists in oncology both in pharmacy-led oncology clinics and research, gaining knowledge and experience.

Anita believes in the power of collaboration that provides the opportunity to share knowledge, empower one another and leverage on created networks for the advancement of oncology pharmacy care.  To this end, she is the Organizing secretary and one of the pioneer pharmacists to establish the Oncology Pharmacists Society of Kenya (OPSoK).

Netty has over 20 years’ experience as a specialist oncology pharmacist working in both government and private organisations within the UK. She is currently Principal Pharmacist – Operations, for Genesis Care UK.   Netty is currently President of The International Society of Oncology Pharmacy Practitioners (ISOPP) and co-chair of the UK SACT Board. Netty has previously held various leadership positions within the British Oncology Pharmacy Association (BOPA) and has independently led several National and International Projects.   Netty was announced a Fellow of the Royal Pharmaceutical Society in 2022 and a Fellow of BOPA in 2023. 

Netty is passionate about improving cancer care globally and improving safety for patients and staff through the use of digital media.  Netty also has a keen interest in education and training and uses her strengths to support all pharmacy staff in all sectors and countries to improve access to learning globally.

Evelyn Handel, PharmD, BCPS, BCOP is Senior Director of Drugs & Biologics Programs at the National Comprehensive Cancer Network in Philadelphia, USA. In this role she collaborates with a multidisciplinary team and is responsible for strategic leadership and management of the NCCN Drugs & Biologics Compendium and the NCCN Chemotherapy Order Templates, which are derivative products of the NCCN Clinical Practice Guidelines in Oncology. Prior to joining NCCN, Evelyn was an oncology clinical pharmacy specialist in various direct patient care roles.

Evelyn is an active member of the International Society of Oncology Pharmacy Practitioners (ISOPP) as well as the Hematology/Oncology Pharmacy Association (HOPA). She has served in multiple volunteer leadership positions including Chair of the HOPA Patient Education Committee, as well as on the ISOPP Secretariat in various roles since 2015 including her current term as immediate Past President and Governance Committee Chair.

Irene holds a master’s degree in clinical pharmacy with specialization in oncology pharmacy from the University of Nairobi and has over 20 years’ experience as a specialist pharmacist, serving in national, regional and international expert advisory and technical working groups. She is an active member of several professional associations and has served on the ISOPP Board since 2020. Irene is an adjunct faculty at the University of Nairobi and Kabarak University, providing research and clinical practice supervision to undergraduate and postgraduate pharmacy students.

Afomia Gebre graduated from Dalhousie’s College of Pharmacy is 2020 and shortly after completed a hospital residency through the Nova Scotia Health Authority. After completing a residency, she went on to work as a hospital pharmacist at the Qikiqtani General Hospital in Iqaluit, Nunavut. Now, she currently works as a clinical pharmacist at the Children's Hospital Eastern Ontario (CHEO). Outside of Pharmacy, Afomia is mainly involved in working with and advocating for members of equity seeking groups.

Shereen Nabhani-Gebara is a  Professor of Oncology at Kingston University London.  She has a doctorate in pharmacy with  post graduate qualifications and specialisation in oncology She has a global view of cancer care as she has trained and worked on three different continents.

She is the vice-chair of the British Oncology Pharmacy Association (BOPA) executive board.

Research focus: evolving cancer services to optimise early detection and follow up care, technology enabled care (including artificial intelligence), and optimising the quality of cancer care through equity and inclusion.

Pieter Ramaut graduated as a pharmacist in 2009 at KU Leuven and completed a ManaMa program in hospital pharmacy in 2012. From 2012 to 2019, he worked in various Flemish hospitals, engaging in a broad spectrum of activities ranging from clinical trials to cardiovascular implants. Since 2019, he has been serving as the head of the production department in the hospital pharmacy of the University Hospital of Ghent (UZ Gent), Belgium. In this role, he oversees pharmaceutical production processes and strives to optimize them using technological advancements.
Additionally, Pieter holds a position as Clinical Guest Professor at Universiteit Gent, where he teaches pharmaceutical technology to ManaMa hospital pharmacists.

A/Prof Alexander is a pharmacist-researcher dedicated to optimizing medication use, improving treatment efficacy, and minimizing toxicities for people living with cancer. As Deputy Director of Pharmacy (Quality and Research) at Peter MacCallum Cancer Centre and an Associate Professor at The University of Melbourne, A/Prof Alexander brings expertise in oncology pharmacy, thoracic cancers, clinical trials, population studies, and research focused on biomarker-driven therapies, pharmacogenomics, longitudinal registries, and biobanking.

Graduated in Pharmacy from the Federal University of Rio Grande do Sul (2012). Master's degree in Hepatology from the Federal University of Health Sciences of Porto Alegre (UFCSPA) (2016). She worked as a pharmacist in the Liver Transplant Group (Santa Casa de Misericórdia - Porto Alegre). Previously, she was a technical support fellow on the project for the Development and Implementation of a Hospital Drug Traceability System by the Observatory of Information and Communication Technologies in Health Systems and Services (OTICS) in partnership with the National Health Surveillance Agency (ANVISA), which was carried out at the Fêmina Hospital (GHC Group) in Porto Alegre/RS. She was a pharmacist at the Clinical Research Center, Moinhos de Vento Hospital for 4 years, where she also worked as a researcher at PROADI. Currently working in clinical research as a Project Manager.

Lee completed her pharmacy training at the University of Toronto, her residency at Sunnybrook Health Sciences Centre in Toronto and her PhD at the University of Amsterdam.  She is an Associate Senior Scientist, Research Institute; a Health Clinician Scientist, Department of Pharmacy, and a Clinical Pharmacist, Haematology/Oncology/Blood and Marrow Transplant/Cellular Therapy at SickKids, Canada and a Professor and Clinician Scientist at the Leslie Dan Faculty of Pharmacy, University of Toronto, Canada.  
Lee has leadership positions within the International Society of Paediatric Oncology (SIOP), the Multi-national Association of Supportive Care in Cancer, the Children’s Oncology Group and the Pediatric Oncology Group of Ontario.  She is the co-founder and co-director of the international Pediatric Oncology supportive care Guideline Network (iPOG Network).
Optimization of the supportive care of children who are receiving cancer treatment or undergoing hematopoietic cell transplant/cellular therapy is the focus of Lee’s research program.  Her work centers on facilitating communication about symptoms by children, evaluating interventions to control treatment-related toxicity and supportive care clinical practice guideline development and implementation.

PhD in Public Health, Specialist in Hospital Pharmacy in Logistics Operations Management. Works as a pharmacist in the Supply Division of the Brazilian National Cancer Institute (INCA), teaching postgraduate courses in Hospital Pharmacy, in INCA's Multiprofessional Residency Program in Oncology and in the Research Program in Collective Health and Cancer Control/INCA. President of the Brazilian Society of Oncology Pharmacists (SOBRAFO) for the 2025-2026 term. She has experience in Service Management, Supply Logistics and teaching in areas of Pharmaceutical Services and Public Procurement.

Jesse Swen PharmD, PhD is a full professor of clinical pharmacy, in particular translational pharmacogenetics. He works as a clinical pharmacist-clinical pharmacologist at the Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center where he is the chair of the laboratory of the hospital pharmacy.  

The long-term central goal of his career is to improve the outcomes of drug treatment by gaining a better understanding of the genetic mechanisms that result in inter-individual variability in drug response.

Dr. Brooke Bernhardt is the Chief Pharmaceutical Officer, Division Director of Pharmaceutical Services, and Associate Member in the Department of Pharmacy and Pharmaceutical Sciences. As a clinician scientist in molecular epidemiology, she aims to discover pharmacogenomic variations which influence treatment-related toxicities in pediatric cancer patients. As a healthcare leader, she strives to advance the practice of pharmacy globally, develop the next generation of pharmacists, reduce the impact of drug shortages, and optimize the pharmacotherapy of pediatric cancer treatment.

Joseph is the Education and Training Lead and Specialist Cancer Pharmacist at The Christie NHS Foundation Trust with a specialist clinical and research interest in colorectal cancer and care closer to home. He is also an independent prescriber within the colorectal cancer speciality. Joseph is an Honorary Clinical Lecturer at the University of Manchester (UoM) where he teaches on the Cancer programme for Undergraduates and Postgraduates. His background has vastly been in clinical practice and his patient facing role within the MDT has allowed him to initiate and progress applied health research projects in his area of practice to benefit patient care. His experience and accolades have allowed Joseph to be elected as Chair of the British Oncology Pharmacy Association (BOPA), elected as a member (and current Co-Chair) of the UK SACT Board, become a member of the UK Pharmacy Professional Leadership (UKPPL) Advisory Board and a Fellow of the Royal Pharmaceutical Society (RPS). Joseph is passionate about promoting excellence in pharmaceutical care of patients with cancer through education, research, and innovation.

Michelle Koberinski has worked in various community and hospital pharmacy settings in BC and Alberta since graduating from Vancouver Community College’s Pharmacy Technician Program in 1999. She currently works for Provincial Pharmacy at BC Cancer as the Oncology Certification Pharmacy Technician where she developed, implements, and maintains an Oncology Certification program for pharmacy staff in British Columbia that prepares and dispenses oncology medication. In 2010, Michelle received CAPhO’s Merit award for her work on the BCCA Pharmacy Practice Standards for Hazardous Drugs Manual. Michelle dedicates much of her time to improving aseptic compounding processes that involve hazardous drugs and developing guidelines for safe practice.

Laura is a Clinical Pharmacy Coordinator in Oncology and Hematology with Nova Scotia Health in Halifax. Laura obtained her BSc from Dalhousie University followed by a PhD in biochemistry from the University of Alberta. She then pursued pharmacy training and a Hospital Pharmacy Residency in Nova Scotia. She has worked with patients in both inpatient and ambulatory oncology settings and has developed and implemented a variety of pharmacist-led clinics. Laura is the CAPhO Research Chair and her research interests include pharmacist prescribing, optimizing patient education of oncology medications, CAR T-cell therapy, and management of toxicities associated with anticancer therapies.

Netty has over 20 years’ experience as a specialist oncology pharmacist working in both government and private organisations within the UK. She is currently Principal Pharmacist – Operations, for Genesis Care UK.   Netty is currently President of The International Society of Oncology Pharmacy Practitioners (ISOPP) and co-chair of the UK SACT Board. Netty has previously held various leadership positions within the British Oncology Pharmacy Association (BOPA) and has independently led several National and International Projects.   Netty was announced a Fellow of the Royal Pharmaceutical Society in 2022 and a Fellow of BOPA in 2023. 

Netty is passionate about improving cancer care globally and improving safety for patients and staff through the use of digital media.  Netty also has a keen interest in education and training and uses her strengths to support all pharmacy staff in all sectors and countries to improve access to learning globally.

Nick is a Consultant Haematology Pharmacist at University Hospitals Birmingham NHS Foundation Trust and an Assistant Professor in the School of Pharmacy at the University of Birmingham. He is a Fellow of the British Oncology Pharmacy Association and the Royal Pharmaceutical Society of Great Britain and is the current Chair of the EBMT Pharmacist Committee. He is the chair of the ISOPP Research Committee, and his areas of research interest include medicines adherence, chronic myeloid leukaemia and antifungal stewardship.

Evelyn Handel, PharmD, BCPS, BCOP is Senior Director of Drugs & Biologics Programs at the National Comprehensive Cancer Network in Philadelphia, USA. In this role she collaborates with a multidisciplinary team and is responsible for strategic leadership and management of the NCCN Drugs & Biologics Compendium and the NCCN Chemotherapy Order Templates, which are derivative products of the NCCN Clinical Practice Guidelines in Oncology. Prior to joining NCCN, Evelyn was an oncology clinical pharmacy specialist in various direct patient care roles.

Evelyn is an active member of the International Society of Oncology Pharmacy Practitioners (ISOPP) as well as the Hematology/Oncology Pharmacy Association (HOPA). She has served in multiple volunteer leadership positions including Chair of the HOPA Patient Education Committee, as well as on the ISOPP Secretariat in various roles since 2015 including her current term as immediate Past President and Governance Committee Chair.

Irene holds a master’s degree in clinical pharmacy with specialization in oncology pharmacy from the University of Nairobi and has over 20 years’ experience as a specialist pharmacist, serving in national, regional and international expert advisory and technical working groups. She is an active member of several professional associations and has served on the ISOPP Board since 2020. Irene is an adjunct faculty at the University of Nairobi and Kabarak University, providing research and clinical practice supervision to undergraduate and postgraduate pharmacy students.